troglitazone and Cancer of Ovary studies

troglitazone and Cancer of Ovary

troglitazone has been researched along with Cancer of Ovary in 3 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

Excerpt	Relevance	Reference
"CGZ and TGZ cause a decrease in ovarian cancer cell proliferation that is PPARγ independent."	1.37	Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner. ( Al-Alem, L; Curry, TE; Kilgore, MW; Southard, RC, 2011)
"Troglitazone (TGZ) is a potential anticancer agent."	1.34	Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line. ( Chen, SL; Ho, TC; Lai, HY; Tsao, YP; Wu, JY; Yang, YC, 2007)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (33.33)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Bräutigam, K	1
Biernath-Wüpping, J	1
Bauerschlag, DO	1
von Kaisenberg, CS	1
Jonat, W	1
Maass, N	1
Arnold, N	1
Meinhold-Heerlein, I	1
Al-Alem, L	1
Southard, RC	1
Kilgore, MW	1
Curry, TE	1
Yang, YC	1
Ho, TC	1
Chen, SL	1
Lai, HY	1
Wu, JY	1
Tsao, YP	1

Studies

Bräutigam, K

Biernath-Wüpping, J

Bauerschlag, DO

von Kaisenberg, CS

Jonat, W

Maass, N

Arnold, N

Meinhold-Heerlein, I

Al-Alem, L

Southard, RC

Kilgore, MW

Curry, TE

Yang, YC

Ho, TC

Chen, SL

Lai, HY

Wu, JY

Tsao, YP

Other Studies

3 other studies available for troglitazone and Cancer of Ovary

Article	Year
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:5 Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Chromans;	2011
Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner. PloS one, 2011, Jan-21, Volume: 6, Issue:1 Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Gene Expression; Humans; Ovarian	2011
Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line. BMC cancer, 2007, Nov-20, Volume: 7 Topics: Cell Line, Tumor; Cell Movement; Chromans; Dose-Response Relationship, Drug; Female; Humans; Ovarian	2007

Article

Year

Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.

Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:5

Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Chromans;

2011

Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.

PloS one, 2011, Jan-21, Volume: 6, Issue:1

Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Gene Expression; Humans; Ovarian

2011

Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line.

BMC cancer, 2007, Nov-20, Volume: 7

Topics: Cell Line, Tumor; Cell Movement; Chromans; Dose-Response Relationship, Drug; Female; Humans; Ovarian

2007